If you are a patient prescribed a UCB neurology product including: BRIVIACT®, VIMPAT®, NEUPRO® and would like to apply for a co-pay assistance card, please contact the program by clicking the appropriate product below:
If you are a patient prescribed CIMZIA® (certolizumab pegol) and would like co-pay assistance, please contact the CIMplicity program at 1-866-4-CIMZIA
If you have public or government sponsored insurance or private commercial insurance, UCBCares has gathered information for resources that may help you afford your medicine.
The following provides a listing of financial assistance resources and foundations that may be of help to you.Click here for Financial Resources beyond UCB
If you do not have health insurance, or have been denied coverage by your health insurance provider, you may be qualified for the UCB Patient Assistance Program. If you believe you qualify for this program, you may download and print the program application below or use the online application link below and follow instructions for returning.Click Here to Download and Print the Patient Assistance Application Click Here to Apply Online
The following Guide was designed as a tool to optimize your choices when selecting a Medicare plan during the annual open enrollment period October to December.Click Here for the Open Enrollment Checklist
For further information, you may also contact UCBCares at 844-599-CARE (2273) for assistance.
At UCB, patients are at the heart of everything we do.
Working with physicians and other healthcare professionals, we engage with patients to better understand their clinical, economic, social and personal needs. What matters most is how we at UCB can add more value to support patients on their healthcare journeys. We’re not just treating a disease; we’re caring for individual people.
Staying true to these core beliefs, UCB is committed to ensuring that all patients, whose physicians have prescribed our medications, are able to access these products. Through the UCB Patient Assistance Program, we provide some medications at no cost to eligible and qualified patients who are uninsured or underinsured who otherwise have no access to the UCB medicines prescribed by their physician. We are committed to an ongoing dialogue with patients, healthcare professionals, insurance companies, policymakers and regulators to promote innovation and new medical discoveries while also doing our part to alleviate some of the cost burden for those living with severe diseases.